Aarkstore.com announces, The Latest market research report is available inits vast collection:Versartis, Inc. – Product Pipeline Review – 2012http://www.aarkstore.com/reports/Versartis-Inc-Product-Pipeline-Review-2012-217927.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “Versartis, Inc. - Product PipelineReview - 2012” provides data on the Versartis, Inc.’s research and developmentfocus. The report includes information on current developmental pipeline, completewith latest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Versartis, Inc.’s corporate website, SEC filings, investorpresentations and featured press releases, both from Versartis, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- Versartis, Inc. - Brief Versartis, Inc. overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Versartis, Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 4List of Figures 4Versartis, Inc. Snapshot 5Versartis, Inc. Overview 5Key Information 5Key Facts 5Versartis, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Versartis, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Pipeline Products – Combination Treatment Modalities 10Versartis, Inc. – Pipeline Products Glance 11Versartis, Inc. Clinical Stage Pipeline Products 11Phase I Products/Combination Treatment Modalities 11Versartis, Inc. – Early Stage Pipeline Products 12Pre-Clinical Products/Combination Treatment Modalities 12Discovery Products/Combination Treatment Modalities 13Versartis, Inc. – Drug Profiles 14VRS-317 14Product Description 14Mechanism of Action 14R&D Progress 14VRS-808 16Product Description 16Mechanism of Action 16R&D Progress 16VRS-826 17Product Description 17Mechanism of Action 17R&D Progress 17VRS-859 + AMX-808 18Product Description 18Mechanism of Action 18R&D Progress 18
Versartis, Inc. – Pipeline Analysis 20Versartis, Inc. – Pipeline Products by Therapeutic Class 20Versartis, Inc. – Pipeline Products By Target 21Versartis, Inc. – Pipeline Products by Route of Administration 22Versartis, Inc. – Pipeline Products By Mechanism of Action 23Versartis, Inc. – Recent Pipeline Updates 24List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1United Therapeutics Corporation – Product Pipeline Review – 2012Vaxon Biotech – Product Pipeline Review – 2012Versartis, Inc. – Product Pipeline Review – 2012ViroStatics, srl – Product Pipeline Review – 2012Viventia Biotechnologies Inc. – Product Pipeline Review – 2012Xencor, Inc. – Product Pipeline Review – 2012
Xention Limited – Product Pipeline Review – 20124-Antibody AG – Product Pipeline Review – 2012Archer Biosciences, Inc – Product Pipeline Review – 2012Bio-Link – Product Pipeline Review – 2012SWITCH Biotech LLC – Product Pipeline Review – 2012Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012TetraLogic Pharmaceuticals – Product Pipeline Review – 2012Tranzyme Pharma, Inc. – Product Pipeline Review – 2012Unigene Laboratories, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports firstname.lastname@example.org
For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: email@example.com